CUDA Trademark

Trademark Overview

On Tuesday, January 31, 2017, a trademark application was filed for CUDA with the United States Patent and Trademark Office. The USPTO has given the CUDA trademark a serial number of 87319037. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 29, 2021. This trademark is owned by Cuda Pharmaceuticals, LLC. The CUDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for ophthalmological use
cuda

General Information

Serial Number87319037
Word MarkCUDA
Filing DateTuesday, January 31, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 29, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 26, 2017

Trademark Statements

Goods and ServicesPharmaceutical products for ophthalmological use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 3, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCuda Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDouglas Manor, NY 11363
Party NameCuda Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDouglas Manor, NY 11363

Trademark Events

Event DateEvent Description
Monday, March 29, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 29, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 17, 2020EXTENSION 5 GRANTED
Friday, July 31, 2020EXTENSION 5 FILED
Monday, August 17, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 31, 2020TEAS EXTENSION RECEIVED
Wednesday, January 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 27, 2020EXTENSION 4 GRANTED
Monday, January 27, 2020EXTENSION 4 FILED
Monday, January 27, 2020TEAS EXTENSION RECEIVED
Thursday, August 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2019EXTENSION 3 GRANTED
Tuesday, July 30, 2019EXTENSION 3 FILED
Tuesday, July 30, 2019TEAS EXTENSION RECEIVED
Friday, February 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2019EXTENSION 2 GRANTED
Wednesday, February 20, 2019EXTENSION 2 FILED
Wednesday, February 20, 2019TEAS EXTENSION RECEIVED
Saturday, August 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2018EXTENSION 1 GRANTED
Thursday, August 16, 2018EXTENSION 1 FILED
Thursday, August 16, 2018TEAS EXTENSION RECEIVED
Tuesday, February 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 26, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 6, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, November 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2017NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2017NON-FINAL ACTION WRITTEN
Wednesday, April 26, 2017ASSIGNED TO EXAMINER
Friday, February 3, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 3, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

cuda ophthalmological products pharmaceutical